跳转至内容
Merck
所有图片(1)

Key Documents

View All Documentation

C-022

Supelco

氯氮卓标准液 溶液

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C16H14ClN3O
CAS号:
58-25-3
分子量:
299.75
EC號碼:
200-659-6
分類程式碼代碼:
41116107
NACRES:
NA.24

等級

certified reference material

形狀

liquid

特點

SNAP-N-SPIKE®, SNAP-N-SHOOT®

包裝

ampule of 1 mL

製造商／商標名

Cerilliant®

drug control

Narcotic Licence Schedule B (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal)

濃度

1.0 mg/mL in methanol

技術

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

應用

clinical testing

格式

single component solution

儲存溫度

−20°C

SMILES 字串

CNC1=C[N+]([O-])=C(c2ccccc2)c3cc(Cl)ccc3N1

InChI

1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-10,18-19H,1H3

InChI 密鑰

VVMUANXXDBQGMO-UHFFFAOYSA-N

一般說明

利眠宁是一种苯二氮卓，商品名为 Librax® 或 Klopoxid，可用于短期治疗焦虑症或管理急性戒酒综合征。 该认证的溶液标准适合用作校准器或对照品中的原材料，用于从法医分析和临床毒理学到尿液药物测试和药物研究等各种 LC/MS 或 GC/MS 应用。

應用


  • Chlordiazepoxide hydrochloride in psychopharmacology: This research chemical is primarily used to investigate the pharmacokinetics and metabolic pathways of benzodiazepines. Studies such as those by Shayesteh et al. have explored the dissociation constants of benzodiazepines, aiding in the development of more effective anxiolytic treatments with a focus on minimizing side effects (Shayesteh et al., 2015).

法律資訊

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
Librax is a registered trademark of Valeant Pharmaceuticals North America LLC
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

訊號詞

Danger

危險分類

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

標靶器官

Eyes

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 1

閃點（°F）

49.5 °F - closed cup

閃點（°C）

9.7 °C - closed cup

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Line V Kristensen et al.
Journal of neurochemistry, 121(3), 373-382 (2012-02-24)
Several metabolic neuroimaging studies have indicated that bipolar patients with mania exhibit alterations in metabolic activity, suggesting that perturbations in corticolimbic function contribute to the functional deficits associated with the disease. Because pharmacological stimulation of K(v)7 channel function has shown
R J Rodgers et al.
Behavioural brain research, 243, 213-219 (2013-01-22)
Although several lines of evidence have recently implicated orexins and their receptors in fear and anxiety, there is also a growing number of apparently inconsistent and/or negative findings. In the present study, we have used ethological methods to comprehensively profile
Ramakrishna Nirogi et al.
Journal of pharmacological and toxicological methods, 65(1), 37-43 (2011-10-25)
Assessment of respiratory safety is one of the most important requirements for new chemical entity (ICH Guideline S7A). The aim of the present study was to compare and validate respiratory safety pharmacology models in conscious rats, to find out the
O M Husain et al.
QJM : monthly journal of the Association of Physicians, 106(1), 43-49 (2012-09-29)
Alcohol-related presentations to hospital have been increasing in the UK in recent years, including the occurrence of acute withdrawal. This study sought to better characterize the clinical features, patterns of treatment and outcomes in this patient group. Patients admitted to
Julian C Leslie et al.
Psychopharmacology, 223(2), 223-235 (2012-04-25)
Effects on the extinction of GABAergic drug, chlordiazepoxide (CDP), and glutamatergic drug, D: -cycloserine (DCS), in C57BL/6 mice were compared. Following a palatability test (Experiment 1), Experiments 2-6 involved food-reinforced lever press training followed by extinction sessions at 1- or
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门